EUVIMEDEUVIMED entdecken
Crossref

Ambenium parenteral: from regulatory approval to clinical practice

Dmitry S Kurilchenko, Dmitry S Kurilchenko, Maya A Kazakova, Maya A Kazakova, Yulia G Kupryashkina, Maria V Feoktistova, Sergey M Kryzhanovsky, Sergey M Kryzhanovsky, Elena I Chukanova

Clinical review for general practice · 25.05.2026 · 7 (3) · 48-52

DOI: 10.47407/kr2026.7.3.00793 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical review for general practice, online erschienen am 25.05.2026. Verfasst von Dmitry S Kurilchenko und 8 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

To assess the clinical rationale for the use of Ambenium® Parenteral in acute pain, primarily in patients with low back pain, based on data from clinical trials and real-world clinical practice.

Methods

A review of publications on the pharmacological properties of phenylbutazone and the study results for Ambenium® Parenteral, containing phenylbutazone and lidocaine, was conducted. Data from a randomized comparative clinical trial in patients with acute low back pain, as well as findings from real-world clinical practice studies in pain syndromes of various origins, were analyzed.

Results

Ambenium® Parenteral was shown to provide an earlier onset of analgesic effect, contribute to a marked reduction in pain intensity, and reduce the proportion of patients with an insufficient response to therapy. In real-world clinical practice studies, the drug demonstrated efficacy in back pain and osteoarthritic joint pain and a good tolerability with short-term use.

Conclusion

Ambenium® Parenteral is a clinically justified option for the treatment of acute pain, combining proven efficacy, rapid onset of analgesic action, and an acceptable safety profile when used according to the approved indications and dosing regimen. Keywords: ambenium, back pain, phenylbutazone, lidocaine.

Zitieren

APA

Kurilchenko, D. S., Kurilchenko, D. S., Kazakova, M. A., Kazakova, M. A., Kupryashkina, Y. G., Feoktistova, M. V., Kryzhanovsky, S. M., Kryzhanovsky, S. M., & Chukanova, E. I. (2026). Ambenium parenteral: from regulatory approval to clinical practice. Clinical review for general practice, 7(3), 48-52. https://doi.org/10.47407/kr2026.7.3.00793

Vancouver

Kurilchenko DS, Kurilchenko DS, Kazakova MA, Kazakova MA, Kupryashkina YG, Feoktistova MV, et al. Ambenium parenteral: from regulatory approval to clinical practice. Clinical review for general practice. 2026;7(3):48-52. doi:10.47407/kr2026.7.3.00793

BibTeX
@article{Kurilchenko2026,
  author = {Kurilchenko, Dmitry S and Kurilchenko, Dmitry S and Kazakova, Maya A and Kazakova, Maya A and Kupryashkina, Yulia G and Feoktistova, Maria V and Kryzhanovsky, Sergey M and Kryzhanovsky, Sergey M and Chukanova, Elena I},
  title = {Ambenium parenteral: from regulatory approval to clinical practice},
  journal = {Clinical review for general practice},
  year = {2026},
  volume = {7},
  number = {3},
  pages = {48--52},
  doi = {10.47407/kr2026.7.3.00793}
}
Kostenlos starten →